Phase I Trial Of The Farnesyltransferase Inhibitor Tipifarnib (R155777) In Combination With Radiotherapy In Patients With Newly Diagnosed Glioblastoma

Oncozone Publications / Radiation Oncology / Online Article Locator

Title:     Phase I Trial Of The Farnesyltransferase Inhibitor Tipifarnib (R155777) In Combination With Radiotherapy In Patients With Newly Diagnosed Glioblastoma
Authors:     E. L. Cohen-Jonathan Moyal*, A. Laprie*, M. Poublanc*, F. Dalenc*, C. Toulas*, B. Alaux*. , Institut Claudius Regaud, Toulouse, France
Presenter:     Cohen-Jonathan Moyal Elizabeth

Keywords :  adjuvant analysis bid biopsy cancer clinical complete concomitant count daily days death diagnosed dlt dose evaluable glioblastoma grade included increase johnson level median mg months mri mtd newly non non-eiaed od patients phase radiotherapy reduction resection response results start study survival tipifarnib total toxicity treatment trial tumor volume week least levels lipids magnetic mb medulloblastoma metabolic methods model mrs order partial plot pls-da ppm pr proton radiation regions resonance results scores spectra spectral squares study tumors vivo x-weights

Click here to access this document

Copyright © ONCOZONE. All rights reserved